USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Fresenius Medical Care Deutschland Gmbh

USPTO PatentsView assignee record - 615 granted patents across 125 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

615

Total patents granted

125

CPC technology areas

16.1

Avg claims per patent

+7%

5-year filing velocity

The verdict

Fresenius holds 615 US patents across 125 technology areas, rank #743 of 50,000 tracked assignees.

#743
of 50,000 US assignees by volume: Top 2%
by Innovation Score (63.2/100): 16.1
avg claims per patent: +7%
filing velocity, last 5 yrs

Portfolio overview

Fresenius Medical Care Deutschland Gmbh has been granted 615 US utility patents between 2015 and 2025, placing Fresenius Medical Care Deutschland Gmbh at rank #743 across all assignees tracked by PlainPatent. This portfolio spans 125 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.1 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a Foreign Corporation, Fresenius Medical Care Deutschland Gmbh is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Fresenius sits between Invensense, Inc. (617 patents, rank #739) and Spectrum Brands, Inc. (612 patents, rank #747) - the closest US assignees by grant volume. The composite Innovation Score of 63.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 318 grants, compared with 297 in the 2015–2019 window, a +7% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Fresenius Medical Care Deutschland Gmbh's 16.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Fresenius Medical Care Deutschland Gmbh against peers pursuing similar technology classes.

Invensense

617
Bell Helicopter T…

616
Suzuki Motor

616
Uchicago Argonne

616
Fresenius Medical… ◀

615
Dexerials

614
Allergan

612
Ford Motor

612
Spectrum Brands

612

What this shows Fresenius holds 615 patents at rank #743, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Fresenius

By rank, the assignees closest to #743 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media INTO)

Other assignees with the most granted patents in Fresenius's primary technology class.

Fresenius's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

63 Top 2% higher than 98% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Fresenius Medical Care Deutschland Gmbh patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	46	7.5%
2016	65	10.6%
2017	67	10.9%
2018	52	8.5%
2019	67	10.9%
2020	60	9.8%
2021	49	8.0%
2022	63	10.2%
2023	37	6.0%
2024	67	10.9%
2025	42	6.8%

Which technologies does Fresenius Medical Care Deutschland Gmbh patent most?

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 539

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 78

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 72

B01D - SEPARATION 62

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 37

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 37

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 30

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 29

A61J - CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE 27

G06F - ELECTRIC DIGITAL DATA PROCESSING 25

F04B - POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS 20

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 19

F16K - VALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING 14

F16L - PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL 13

G01M - TESTING STATIC OR DYNAMIC BALANCE OF MACHINES OR STRUCTURES; TESTING OF STRUCTURES OR APPARATUS, NOT OTHERWISE PROVIDED FOR 11

Top 15 of 125 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Diversified

Claim Depth Standard

Velocity Growing

Where it ranks

Overall rank by patents

#743

Across all tracked assignees

Innovation Score

63.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Fresenius Medical Care Deutschland Gmbh hold?

Fresenius Medical Care Deutschland Gmbh holds 615 US granted patents filed between 2015 and 2025, spanning 125 technology areas.

What is Fresenius Medical Care Deutschland Gmbh's Innovation Score?

Fresenius Medical Care Deutschland Gmbh has an Innovation Score of 63.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Fresenius Medical Care Deutschland Gmbh focus on?

Fresenius Medical Care Deutschland Gmbh's top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 539 patents. The company has filed patents in 125 CPC subclasses total.

Is Fresenius Medical Care Deutschland Gmbh's patent filing rate increasing or decreasing?

Fresenius Medical Care Deutschland Gmbh's recent filing velocity is +7% compared to the prior five-year period. The company is maintaining or growing its patent output.

What does claim depth mean for Fresenius Medical Care Deutschland Gmbh's patents?

Fresenius Medical Care Deutschland Gmbh's patents average 16.1 claims each. This falls within the standard range, providing solid legal coverage.

How is the Fresenius Medical Care Deutschland Gmbh patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Fresenius's 615 grants land it in the top 2% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Fresenius ranks #743 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61M - see who else leads that technology area. A61M leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.